Loopbaan van Andrea Grant
Eerdere bekende functies van Andrea Grant
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Directeur/Bestuurslid | 16-11-2012 | 01-04-2014 |
| Algemeen Directeur | 28-12-2011 | 01-04-2014 | |
| Investor Relations Contact | 28-12-2011 | 01-04-2014 | |
| Public Communications Contact | 28-12-2011 | 01-04-2014 | |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Corporate Officer/Principal | - | 02-05-2008 |
Diatranz Otsuka Ltd.
 Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Algemeen Directeur | 01-04-2014 | - |
Opleiding van Andrea Grant
| University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
| Nieuw-Zeeland | 3 |
| België | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Health Technology |
Diatranz Otsuka Ltd.
Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Health Technology |
- Beurs
- Insiders
- Andrea Grant
- Ervaring